These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 29860282)

  • 41. Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    Liu H; Lutz M; Luo S;
    J Alzheimers Dis; 2021; 84(3):1323-1335. PubMed ID: 34657885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer's disease.
    Hayes JP; Logue MW; Sadeh N; Spielberg JM; Verfaellie M; Hayes SM; Reagan A; Salat DH; Wolf EJ; McGlinchey RE; Milberg WP; Stone A; Schichman SA; Miller MW
    Brain; 2017 Mar; 140(3):813-825. PubMed ID: 28077398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease.
    Miron J; Picard C; Nilsson N; Frappier J; Dea D; Théroux L; ; ; Poirier J
    Alzheimers Dement; 2018 Jun; 14(6):787-796. PubMed ID: 29360470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genome-wide association study identifies
    Li X; Chu SG; Shen XN; Hou XH; Xu W; Ou YN; Dong Q; Tan L; Yu JT
    Aging (Albany NY); 2019 Nov; 11(21):9862-9874. PubMed ID: 31711042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
    Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
    J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genome-wide association study identifies susceptibility loci of brain atrophy to NFIA and ST18 in Alzheimer's disease.
    Kim BH; Nho K; Lee JM;
    Neurobiol Aging; 2021 Jun; 102():200.e1-200.e11. PubMed ID: 33640202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease.
    Nho K; Horgusluoglu E; Kim S; Risacher SL; Kim D; Foroud T; Aisen PS; Petersen RC; Jack CR; Shaw LM; Trojanowski JQ; Weiner MW; Green RC; Toga AW; Saykin AJ;
    BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):30. PubMed ID: 27535542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
    Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
    Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural Neuroimaging Genetics Interactions in Alzheimer's Disease.
    Moon SW; Dinov ID; Kim J; Zamanyan A; Hobel S; Thompson PM; Toga AW
    J Alzheimers Dis; 2015; 48(4):1051-63. PubMed ID: 26444770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study.
    Jia L; Li F; Wei C; Zhu M; Qu Q; Qin W; Tang Y; Shen L; Wang Y; Shen L; Li H; Peng D; Tan L; Luo B; Guo Q; Tang M; Du Y; Zhang J; Zhang J; Lyu J; Li Y; Zhou A; Wang F; Chu C; Song H; Wu L; Zuo X; Han Y; Liang J; Wang Q; Jin H; Wang W; Lü Y; Li F; Zhou Y; Zhang W; Liao Z; Qiu Q; Li Y; Kong C; Li Y; Jiao H; Lu J; Jia J
    Brain; 2021 Apr; 144(3):924-937. PubMed ID: 33188687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
    Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P
    J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.
    Saykin AJ; Shen L; Foroud TM; Potkin SG; Swaminathan S; Kim S; Risacher SL; Nho K; Huentelman MJ; Craig DW; Thompson PM; Stein JL; Moore JH; Farrer LA; Green RC; Bertram L; Jack CR; Weiner MW;
    Alzheimers Dement; 2010 May; 6(3):265-73. PubMed ID: 20451875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multimodal Brain Imaging Reveals Structural Differences in Alzheimer's Disease Polygenic Risk Carriers: A Study in Healthy Young Adults.
    Foley SF; Tansey KE; Caseras X; Lancaster T; Bracht T; Parker G; Hall J; Williams J; Linden DE
    Biol Psychiatry; 2017 Jan; 81(2):154-161. PubMed ID: 27157680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment.
    Hu X; Pickering EH; Hall SK; Naik S; Liu YC; Soares H; Katz E; Paciga SA; Liu W; Aisen PS; Bales KR; Samad TA; John SL
    Transl Psychiatry; 2011 Nov; 1(11):e54. PubMed ID: 22833209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
    Dukart J; Sambataro F; Bertolino A
    J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Susceptibility of brain atrophy to
    Lorenzi M; Altmann A; Gutman B; Wray S; Arber C; Hibar DP; Jahanshad N; Schott JM; Alexander DC; Thompson PM; Ourselin S;
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3162-3167. PubMed ID: 29511103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting conversion from mild cognitive impairment to Alzheimer's disease: a multimodal approach.
    Agostinho D; Simões M; Castelo-Branco M
    Brain Commun; 2024; 6(4):fcae208. PubMed ID: 38961871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's disease in the ADNI cohort.
    Meda SA; Narayanan B; Liu J; Perrone-Bizzozero NI; Stevens MC; Calhoun VD; Glahn DC; Shen L; Risacher SL; Saykin AJ; Pearlson GD
    Neuroimage; 2012 Apr; 60(3):1608-21. PubMed ID: 22245343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.